| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 3,517,630 | 3,257,352 | 3,150,762 | 4,016,638 | | Cost of Revenue | 1,577,413 | 1,513,574 | 1,467,507 | 1,790,954 | | | Gross Profit | 1,940,217 | 1,743,778 | 1,683,255 | 2,225,684 | | | Operating Expenses | | Research Development | 422,092 | 397,881 | 383,293 | 434,521 | | Selling General and Administrative | 1,177,775 | 1,051,204 | 1,024,773 | 1,211,120 | | Non Recurring | 34,781 | 33,234 | 15,572 | 247,270 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 305,569 | 261,459 | 259,617 | 332,773 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 66,128 | 31,360 | 29,086 | 35,944 | | Earnings Before Interest And Taxes | 371,697 | 292,819 | 288,703 | 368,717 | | Interest Expense | 46,227 | 44,158 | 45,543 | 18,446 | | Income Before Tax | 325,470 | 248,661 | 243,160 | 350,271 | | Income Tax Expense | 20,602 | 38,045 | 37,815 | 44,569 | | Minority Interest | (23,348) |
-
|
-
| (17,718) | | | | Net Income From Continuing Ops | 281,520 | 210,616 | 205,345 | 287,984 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 281,520 | 210,616 | 205,345 | 287,984 | | Preferred Stock And Other Adjustments | 16,660 | (5,384) | (11,276) |
-
| | | Net Income Applicable To Common Shares | $298,180 | $205,232 | $194,069 | $287,984 |
|
0.22% Nasdaq 
Income Statement
